Imunon Inc. has announced its receipt of a delisting notice from Nasdaq due to non-compliance with the Minimum Bid Price Requirement, which mandates a minimum bid price of $1.00 per share. This notice follows the company's failure to meet the requirement over a 30 consecutive business day period. Despite requesting a hearing before a Nasdaq Hearing Panel to appeal the delisting determination, Imunon was granted an exception to regain compliance with both the Minimum Bid Price Requirement and the Minimum Stockholders' Equity Requirement. The company faces challenges in regaining compliance and potential complications if its securities are delisted from Nasdaq. Imunon must promptly notify the Panel of any significant developments that could impact its compliance status.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。